[18F]-Fluorodeoxyglucose–Positron Emission Tomography in Patients With Active Myelopathy
Authors:
- Eoin P. FlanaganEFEoin P. Flanagan
- Christopher H. HuntCHChristopher H. Hunt
- Val LoweVLVal Lowe
- Jay MandrekarJMJay Mandrekar
- Sean J. PittockSPSean J. Pittock
- Brian Patrick O'NEillBOBrian Patrick O'NEill
- B. Mark KeeganBKB. Mark Keegan
- 1 November 2013
- journal article
- research article
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 88 (11) , 1204-1212
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteriaAnnals of Neurology, 2011
- FDG-PET/MRI coregistration improves detection of cortical dysplasia in patients with epilepsyNeurology, 2008
- Autoimmune myelopathy associated with collapsin response‐mediator protein‐5 immunoglobulin GAnnals of Neurology, 2008
- 18F-FDG PET/CT in primary central nervous system lymphoma in HIV-negative patientsNuclear Medicine Communications, 2007
- Primary intramedullary primitive neuroectodermal tumor of the cervical spinal cordJournal of Neurosurgery: Spine, 2006
- Positron-Emission Tomography and Assessment of Cancer TherapyNew England Journal of Medicine, 2006
- Leptomeningeal Carcinomatosis and Intramedullary Spinal Cord Metastases from Lung CancerClinical Nuclear Medicine, 2001
- Intramedullary Spinal Cord Metastasis from Renal Cell CarcinomaClinical Nuclear Medicine, 2001
- Intramedullary spinal cord metastasis from carcinoma of the lung: detection by positron emission tomographyEuropean Journal of Cancer, 1997
- Intramedullary spinal cord metastasesNeurology, 1996